KING ANDREW JAMES enters JADE BIOSCIENCES, INC. with 344.86K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/1/2025ACC: 0000950170-25-062026
Officer· See Remarks
Since Feb 2026
344.86K
Baseline shares
100% direct
344.86K
Direct ownership
1 position
1M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned344.86K
Total
344.86K direct344.86K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 344.86K | Direct |
| Total | 344.86K | 344.86K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
185.40K
Shares owned
N/A
Exercise price
2.32
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
238.89K
Shares owned
N/A
Exercise price
6.03
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
27.59K
Shares owned
N/A
Exercise price
0.5
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
552.71K
Shares owned
N/A
Exercise price
6.03
Expiration
—
Exercise window
—
Total
Underlying
1M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 2.32 | — | — | 185.40K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.03 | — | — | 238.89K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.5 | — | — | 27.59K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.03 | — | — | 552.71K | N/A |
| Total | 1M | 0.00 | ||||